Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Related content
Volume 2, Number 7, July 2004

< previous issue | all issues | next issue >

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99
pp. 1047-1054(8)
Authors: Darby, S. C.; Keeling, D. M.; Spooner, R. J. D.; Wan Kan, S.; Giangrande, P. L. F.; Collins, P. W.; Hill, F. G. H.; Hay, C. R. M.

Favourites:Add to Favourites

Free Content Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis
pp. 1058-1070(13)
Authors: Mismetti, P.; Laporte, S.; Zufferey, P.; Epinat, M.; Decousus, H.; Cucherat, M.

Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies
pp. 1077-1081(5)
Authors: Nash, M. J.; Camilleri, R. S.; Kunka, S.; Mackie, I. J.; Machin, S. J.; Cohen, H.

Favourites:Add to Favourites

Free Content Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey
pp. 1096-1103(8)
Authors: Poon, M-C.; D'Oiron, R.; Von Depka, M.; Khair, K.; Négrier, C.; Karafoulidou, A.; Huth-Kuehne, A.; Morfini, M.

Favourites:Add to Favourites

Free Content Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX
pp. 1104-1109(6)
Authors: Van Der Heijden, J. F.; Rekké, B.; Hutten, B. A.; Van Der Meer, F. J. M.; Remkes, M. G. H.; Vermeulen, M.; Büller, H. R.; Reitsma, P. H.

Favourites:Add to Favourites

Free Content Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study
pp. 1110-1117(8)
Authors: Ten Wolde, M.; Hagen, P. J.; Macgillavry, M. R.; Pollen, I. J.; Mairuhu, A. T. A.; Koopman, M. M. W.; Prins, M. H.; Hoekstra, O. S.; Brandjes, D. P. M.; Postmus, P. E.; Büller, H. R.

Favourites:Add to Favourites

Free Content Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists
pp. 1118-1126(9)
Authors: Morel, O.; Hugel, B.; Jesel, L.; Mallat, Z.; Lanza, F.; Douchet, M-P.; Zupan, M.; Chauvin, M.; Cazenave, J-P.; Tedgui, A.; Freyssinet, J-M.; Toti, F.

Favourites:Add to Favourites

Free Content Role of the γ-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin–heparin
pp. 1127-1134(8)
Authors: Whinna, H. C.; Lesesky, E. B.; Monroe, D. M.; High, K. A.; Larson, P. J.; Church, F. C.

Favourites:Add to Favourites

Free Content A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers
pp. 1135-1142(8)
Authors: O'Brien, L. A.; Sutherland, J. J.; Hegadorn, C.; Benford, K.; Racz, H.; Rapson, D.; Hough, C.; Lillicrap, D.

Favourites:Add to Favourites

Free Content Two novel mutations in EGF-like domains of human factor IX dramatically impair intracellular processing and secretion
pp. 1143-1154(12)
Authors: Enjolras, N.; Plantier, J-L.; Rodriguez, M-H.; Rea, M.; Attali, O.; Vinciguerra, C.; Negrier, C.

Favourites:Add to Favourites

Free Content Rapid and efficient incorporation of tissue factor into liposomes
pp. 1155-1162(8)
Authors: Smith, S. A.; Morrissey, J. H.

Favourites:Add to Favourites

Free Content Enhancement of enzymatic fibrinolysis with 2-MHz ultrasound and microbubbles
pp. 1163-1166(4)
Authors: Cintas, P.; Nguyen, F.; Boneu, B.; Larrue, V.

Favourites:Add to Favourites

Free Content A novel Phe171Cys mutation in integrin αIIb causes Glanzmann thrombasthenia by abrogating αIIbβ3 complex formation
pp. 1167-1175(9)
Authors: Rosenberg, N.; Landau, M.; Luboshitz, J.; Rechavi, G.; Seligsohn, U.

Favourites:Add to Favourites

Free Content Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies
pp. 1176-1181(6)
Authors: Dunoyer-Geindre, S.; Kruithof, E. K. O.; Boehlen, F.; Satta-Poschung, N.; Reber, G.; de Moerloose, P.

Favourites:Add to Favourites

Free Content Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications
pp. 1182-1183(2)
Authors: Zotz, R. B.; Gerhardt, A.; Scharf, R. E.

Favourites:Add to Favourites

Free Content Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications
pp. 1187-1188(2)
Authors: Grandone, E.; Margaglione, M.

Favourites:Add to Favourites

Free Content Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications
pp. 1188-1189(2)
Authors: Wells, P. S.; Rodger, M. A.

Favourites:Add to Favourites

Free Content Screening for thrombophilia in children: a puzzling decision with unclear implications
pp. 1193-1194(2)
Authors: Tormene, D.; Pagnan, A.; Prandoni, P.; Simioni, P.

Favourites:Add to Favourites

Free Content Does heparin therapy improve pregnancy outcome in patients with thrombophilias?
pp. 1194-1195(2)
Authors: Paidas, M.; Ku, D.-H.; Triche, E.; Lockwood, C.; Arkel, Y.

Favourites:Add to Favourites

Free Content Association between the acquired free protein S deficiency in HIV-infected patients with the lipid profile levels
pp. 1195-1197(3)
Authors: De Larrañaga, G.; Perés, S.; Puga, L.; Alonso, B.; Benetucci, J.

Favourites:Add to Favourites

Free Content Protein Z gene polymorphisms are associated with protein Z plasma levels
pp. 1197-1199(3)
Authors: Santacroce, R.; Cappucci, F.; Di Perna, P.; Sessa, F.; Margaglione, M.

Favourites:Add to Favourites

Free Content Tissue factor expression and P2Y12 gene polymorphism
pp. 1199-1200(2)
Authors: Reny, J-L.; Gaussem, P.; Remones, V.; Emmerich, J.; Fontana, P.

Favourites:Add to Favourites

Free Content Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism
pp. 1204-1206(3)
Authors: Leclercq, M. G. L.; Kruip, M. J. H. A.; Mac Gillavry, M. R.; Van Marwijk Kooy, M.; Büller, H. R.

Favourites:Add to Favourites

Free Content Effect of age on the assessment of clinical probability of pulmonary embolism by prediction rules
pp. 1206-1208(3)
Authors: Righini, M.; Le Gal, G.; Perrier, A.; Bounameaux, H.

Favourites:Add to Favourites

Free Content Potassium homeostasis in patients receiving prophylactic dose enoxaparin therapy
pp. 1208-1209(2)
Authors: Potti, A.; Danielson, B.; Badreddine, R.; Ortel, T.

Favourites:Add to Favourites

Free Content Search for red blood cell cytoskeleton abnormalities in patients with venous thrombosis
pp. 1209-1210(2)
Authors: Chariout, S.; Ffrench, P.; Hanss, M.

Favourites:Add to Favourites

Free Content Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients
pp. 1211-1212(2)
Authors: Rodrigues, C. A.; Rocha, L. K. A.; Morelli, V. M.; Franco, R. F.; Lourenço, D. M.

Favourites:Add to Favourites

Free Content Hyperhomocysteinemia and severity of peripheral vascular disease: a rebuttal
pp. 1212-1213(2)
Authors: Haltmayer, M.; Mueller, T.; Poelz, W.

Favourites:Add to Favourites

Free Content Hyperchomocysteinemia and severity of peripheral vascular disease: reply to a rebuttal
pp. 1214-1214(1)
Authors: Ciccarone, E.; Salcuni, N. B.; Donati, M. B.; Iacoviello, L.

Favourites:Add to Favourites

Free Content More on: cellular microparticles: what are they bad or good for?
pp. 1215-1216(2)
Authors: Ahn, Y. S.; Jy, W.; Jimenez, J. J.; Horstman, L. L.

Favourites:Add to Favourites

Free Content Aspirin and platelet function
pp. 1216-1218(3)
Author: Breddin, H. K.

Favourites:Add to Favourites

Free Content Ilsley Ingram
pp. 1219-1219(1)
Author: Mannucci, P. M.

Favourites:Add to Favourites

Free Content TALKING ABOUT…
pp. 1220-1222(3)
Authors: Bruttomesso, G.; Miglino, N.

Favourites:Add to Favourites

Free Content ANNOUNCEMENTS
pp. 1223-1223(1)

Favourites:Add to Favourites

Free Content Erratum
pp. 1224-1224(1)

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more